Diabetes Conference-NFOD 2026

Cardiometabolic risk reduction is critical in diabetes management, as patients are at increased risk of cardiovascular disease, stroke, and metabolic complications. Comprehensive strategies involve lifestyle interventions such as balanced nutrition, regular physical activity, weight management, and smoking cessation to improve metabolic parameters and reduce cardiovascular risk. Pharmacological therapies, including antihypertensives, statins, antiplatelet agents, and glucose-lowering medications with cardioprotective effects, play a pivotal role in mitigating risk. Regular monitoring of blood pressure, lipid profiles, and glycemic control enables timely adjustments to therapy. By adopting an integrated, patient-centered approach that combines lifestyle modification, pharmacologic treatment, and preventive care, healthcare providers can effectively reduce cardiometabolic risk, enhance quality of life, and prevent long-term complications in individuals with diabetes.